Home
DrugRxiv Drug Repurposing Network Medicine
REPO4EU Meet the team Drug Repurposing Research Collection Conference
Blog
Register Dashboard
Search
Home
DrugRxiv Drug Repurposing Network Medicine
REPO4EU Meet the team Drug Repurposing Research Collection Conference
My ScienceOpen

Register Dashboard
Search
268
views
Article has an altmetric score of 1
1
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
1 collections
    1
    shares
      145
      similar
       All similar
      scite_
      0
      0
      0
      0
      Smart Citations
      0
      0
      0
      0
      Citing PublicationsSupportingMentioningContrasting
      View Citations

      See how this article has been cited at scite.ai

      scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

       
      • Record: found
      • Abstract: found
      • Conference Proceedings: found
      Is Open Access

      Chemogenomic screening in patient-derived tissue models enables target identification and drug repurposing

      Published
      conference-abstract
      Author(s): 1 , 2 , 3
      Publication date (Electronic, pub):
      Publisher: REPO4EU
      Conference name: RExPO23
      Conference date: 25-26 October 2023
      Keywords: 3D human tissue models, translational pharmacology, precision drug development
      Bookmark

            Abstract

            Content

            Author and article information

            Conference
            Publisher: REPO4EU
            Publication date (Electronic, pub): 4 October 2023
            Affiliations
            [1 ] Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm (Sweden) ( https://ror.org/056d84691)
            [2 ] Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart (Germany) ( https://ror.org/02pnjnj33)
            [3 ] University of Tübingen, Tübingen (Germany) ( https://ror.org/03a1kwz48)
            Author information
            https://orcid.org/0000-0002-1140-6204
            Article
            DOI: 10.58647/REXPO.23017
            SO-VID: add6b1a1-68c2-4670-9516-e490c268e518
            Copyright © Authors
            License:

            Published under Creative Commons Attribution 4.0 International ( CC BY 4.0). Users are allowed to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source.

            Conference name: RExPO23
            Conference number: 2
            Conference location: Stockholm, Sweden
            Conference date: 25-26 October 2023
            History
            Product

            REPO4EU

            Categories

            Data availability: Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            ScienceOpen disciplines: Pharmacology & Pharmaceutical medicine
            Keywords: 3D human tissue models,translational pharmacology,precision drug development

            References

            1. Stebbing Justin, Lauschke Volker M.. JAK Inhibitors — More Than Just Glucocorticoids. New England Journal of Medicine. Vol. 385(5):463–465. 2021. Massachusetts Medical Society. [Cross Ref]

            Comments

            Comment on this article